Clinical Trials Logo

Clinical Trial Summary

This study is a prospective, multi-center, randomized controlled clinical trial, aims to assess the safety and effectiveness of Optical Coherence Tomography or Intravascular Ultrasound or Quantitative Coronary Analysis to guide Firehawk stent implantation , and compared the treatment of moderate-to-severe calcified lesion in coronary artery.


Clinical Trial Description

This clinical trial will enroll 375 subjects and assign to groups in a 1:1:1 ratio (base on Intravascular Ultrasound [IVUS]-guided treatment group : Optical Coherence Tomography [OCT]-guided treatment group : Quantitative Coronary Angiography [QCA]-guided treatment group) who have moderate-severe calcified lesions in de novo native coronary artery with ≥2.50 mm to ≤4.00 mm in diameter (visual measurement) from a maximum of 25 study sites in China. After the stent is implanted satisfactorily, OCT examinations will be performed on the subjects of these three groups to observe stent expansion after implantation. At 13 months after procedure, all subjects will receive QCA examination.

OCT sub-group study: The initial 66 ongoing subjects from the three treatment groups (IVUS-guided treatment group : OCT-guided treatment group : QCA-guided treatment group) who provided informed consent and successfully randomized will receive OCT examinations at three months follow up after baseline procedure. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03574636
Study type Interventional
Source Shanghai MicroPort Medical (Group) Co., Ltd.
Contact Ming Zheng, MD
Phone (86)(21)38954600-6229
Email mzheng@microport.com
Status Recruiting
Phase N/A
Start date October 18, 2019
Completion date September 2025

See also
  Status Clinical Trial Phase
Completed NCT05517889 - Repeatability and Stability of Healthy Skin Features on OCT
Recruiting NCT04121611 - Optical Coherence Tomography Guided Antithrombotic Treatment After Endovascular Thrombectomy of the Posterior Circulation N/A
Not yet recruiting NCT06040073 - Natural History of Coronary Atherosclerosis
Recruiting NCT05230446 - PRospective Evaluation of Complete Revascularization in Patients With multiveSsel Disease Excluding chroNic Total Occlusions N/A
Completed NCT04698902 - Influence of Calcium Pattern on Plaque Modification Achieved With Intracoronary Lithotripsy
Completed NCT04794634 - Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers N/A
Recruiting NCT04150016 - In-stent Repair and Vessel Reaction of STEMI Patients With OCT N/A
Completed NCT03209843 - Post-stenting Assessment of Reendothelialization With OFDI After CTO Procedure (PERFECTO) N/A
Recruiting NCT03593928 - Optical Coherence Tomography Examination in Acute Myocardial Infarction
Recruiting NCT05340361 - Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT
Not yet recruiting NCT01557205 - Research and System Development on Functional 3D Optical Tomography for Skin Cell Imaging N/A
Recruiting NCT05550077 - Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
Recruiting NCT03474432 - SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI N/A
Recruiting NCT06043622 - Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg® Optical Coherence Tomography Angiography N/A
Enrolling by invitation NCT04499768 - A Longitudinal Study of Choroidal Changes After Cataract Surgery in Eyes With Diabetic Retinopathy
Completed NCT05223205 - Optical Coherence Tomography Angiography Characteristics of Patients With Surgically Closed Full-thickness Idiopathic Macular Holes < 600 μm With Air Versus 10% SF6 Tamponade N/A
Recruiting NCT04855500 - A Single Center Registry of Coronary OCT
Active, not recruiting NCT03848078 - (Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC) N/A
Not yet recruiting NCT03390205 - OCT Angiography in Vitreo and Chorioretinal Pathologies N/A
Active, not recruiting NCT05041777 - Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma